Peripheral blood telomerase activity in non-Hodgkin lymphoma

Research Communications in Molecular Pathology and Pharmacology

Volumn 113-114, Issue , 2003, Pages 298-306

  Onur, Ibrahim ^a   Akman, Serif ^a   Olgun, Abdullah ^a   Fen, Turgay ^b   Kutluay, Türker ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

Non Hodgkin lymphoma; Patients; Peripheral blood; Telomerase

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CELL IMMORTALIZATION; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TELOMERASE;

EID: 13144257692     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blackburn EH: Structure and function of telomeres. (1991). Nature 350:569-573.
2. Broccoli D, Young JW, De lange T. (1995). Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:9082-9086.
3. Brousset P, Al Saati T, Chaouche N, Zenou RC, Schlaifer D, Chittal S, Delsol G. (1997). Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 89:26-31.
4. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM. (1996). Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow; Stem Cells 14:239-248.
5. Counter CM, Gupta J, Harley CB, Leber B, Baccketli S. (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320.
6. Counter CM, Hirte HW, Bacchetti, Harley CB. (1994). Telomerase activity in vitro in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904.
7. Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM. (2000). Telomerase Activity in B-Cell Non-Hodgkin Lymphomas. Cancer 89:445-452.
8. Hiyama K, Hira Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, İshioka S, Yamakido M. (1995). Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol 155:3711-3715.
9. Igerashi H, Sakaguchi N. (1997). Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299-1307.
10. Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Kawakubo K, Shay JW, Toyama K. (1997). The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer 79:1552-1560.
11. Kim NW, Piatyszek MA, Pravse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
12. Norrback KF, Enblad G, Erlanson M, Sundström C, Roos G. (1998). Telomerase Activity in Hodgkin's Disease. Blood 92:567-573.
13. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K. (1997). Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 11:190-194.
14. Rhyu M. Telomeres, telomerase and immortality. (1995). J Natl Cancer Inst 87:884-894.
15. Shay JW, Bacchetti S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791.
16. Treutin L, Zambello R, Benati C, Cassatella M, Agostini C, Bulian P, Adami F, Carra G, Pizzolo G, Semenzato G. (1992). Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells. Cancer Res 52:5223-5228.
17. Weng NP, Hathcock KS, Hodes RJ. (1998). Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9:151-157.
18. Weng NP, Levine BL, June CH, Hodes RJ. (1996). Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183: 2471-2479.
19. Zakian VA. (1995). Telomeres: Beginning to understand the end. Science 270:1601-1607.
20. Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreef M, Deisseroth AB, Wright WE, Shay JW. (1996). Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents; Clin Cancer Res 2:799-803.